Discovery and development of HIV protease inhibitors
Many major physiological processes depend on regulation of proteolytic enzyme activity and there can be dramatic consequences when equilibrium between an enzyme and its substrates is disturbed.
Find news
Sponsors
"Hope is the only bee that makes honey without flowers."
Ambrilia Biopharma Provides Bi-Weekly Update on its Status - MarketWatch (press release)
Posted by admin / Under Discovery And Development Of HIV Protease Inhibitors
Ambrilia Biopharma Provides Bi-Weekly Update on its Status MarketWatch (press release) Ambrilia Biopharma Inc. (THE:CA:AMB) is a biotechnology company focused on the discovery and development of novel treatments for viral diseases and cancer. ... |
Published on Monday 6th of September 2010 04:19:11 PM
Achillion Reports Second Quarter and Six Month Financial Results - MarketWatch (press release)
Posted by admin / Under Discovery And Development Of HIV Protease Inhibitors
Achillion Reports Second Quarter and Six Month Financial Results MarketWatch (press release) "Our lead protease inhibitor, ACH-1625, continued to demonstrate excellent potency, safety and tolerability in the final two dosing cohorts we just ... |
Published on Monday 6th of September 2010 04:19:11 PM
Cash Register Keeps Ringing for Tobira Therapeutics - cbl - Citybizlist (press release)
Posted by admin / Under Discovery And Development Of HIV Protease Inhibitors
Cash Register Keeps Ringing for Tobira Therapeutics - cbl Citybizlist (press release) Dr Fischer was responsible for the launch of Invirase, the first protease inhibitor, and Sustiva the first once-daily anti-HIV now part of the triple ... |
Published on Monday 6th of September 2010 04:19:11 PM
Vertex Pharmaceuticals Announces Webcast of its Presentation at the Canaccord ... - MarketWatch (press release)
Posted by admin / Under Discovery And Development Of HIV Protease Inhibitors
Vertex Pharmaceuticals Announces Webcast of its Presentation at the Canaccord ... MarketWatch (press release) Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline. Lexiva is a registered trademark of the GlaxoSmithKline group of companies. |
Published on Monday 6th of September 2010 04:19:11 PM
Phase 3 ILLUMINATE Study Supports 24-Week Telaprevir-Based - BioResearch Online (press release)
Posted by admin / Under Discovery And Development Of HIV Protease Inhibitors
Phase 3 ILLUMINATE Study Supports 24-Week Telaprevir-Based BioResearch Online (press release) Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline. Lexiva is a registered trademark of the GlaxoSmithKline group of companies. ... |
Published on Monday 6th of September 2010 04:19:11 PM
Our Services
Do not forget to check the lastest products and auctions related to Discovery And Development Of HIV Protease Inhibitors as well as our free videos and podcasts.
This Day In History
William McKinley: US president was shot by an anarchist; he died eight days later (1901)
Share this!